Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Irvine

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Blood|January 7, 2012
Targeting hedgehog in hematologic malignancyDavid A Irvine, Mhairi Copland
Blood Reviews|December 17, 2009
Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors--a synthesis of clinical and laboratory dataDavid A Irvine, Nicholas B Heaney, Tessa L Holyoake
Journal of Chromatography. A|September 1, 2005
Analysis of VX nerve agent hydrolysis products in wastewater effluents by ion chromatography with amperometric and conductivity detectionHaishan Piao, Randall B Marx, Steven Schneider, et al.
Optics Express|January 29, 2025
Comparative autofluorescence analysis of silicon nitride and tantalum pentoxide waveguides at 532 nmDavid A Irvine, Ephrata Zelleke, Aaron T Schreyer, et al.
Scientific Reports|May 10, 2016
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemiaDavid A Irvine, Bin Zhang, Ross Kinstrie, et al.
Blood|July 10, 2013
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profileKimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner, et al.
Nature Medicine|November 11, 2024
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trialKate Cwynarski, Gloria Iacoboni, Eleni Tholouli, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Blood|January 7, 2012
Targeting hedgehog in hematologic malignancyDavid A Irvine, Mhairi Copland
Blood Reviews|December 17, 2009
Optimising chronic myeloid leukaemia therapy in the face of resistance to tyrosine kinase inhibitors--a synthesis of clinical and laboratory dataDavid A Irvine, Nicholas B Heaney, Tessa L Holyoake
Journal of Chromatography. A|September 1, 2005
Analysis of VX nerve agent hydrolysis products in wastewater effluents by ion chromatography with amperometric and conductivity detectionHaishan Piao, Randall B Marx, Steven Schneider, et al.
Optics Express|January 29, 2025
Comparative autofluorescence analysis of silicon nitride and tantalum pentoxide waveguides at 532 nmDavid A Irvine, Ephrata Zelleke, Aaron T Schreyer, et al.
Scientific Reports|May 10, 2016
Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemiaDavid A Irvine, Bin Zhang, Ross Kinstrie, et al.
Blood|July 10, 2013
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profileKimberly Cramer-Morales, Margaret Nieborowska-Skorska, Kara Scheibner, et al.
Nature Medicine|November 11, 2024
TRBC1-CAR T cell therapy in peripheral T cell lymphoma: a phase 1/2 trialKate Cwynarski, Gloria Iacoboni, Eleni Tholouli, et al.
Pageof 1